Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Sitka Biopharma
489
Sitka Biopharma
Technology
Biotechnology
Sitka Biopharma is developing a new bladder #cancer treatment - a polymer compound that allows taxane drugs to adhere to the bladder wall.
Suggest edits
Type
B2b
Founded
2013
Raised
$4.3M
Follow us
Companies in the same industry
MassChallenge
UWI Technology
ChromaDex
Personalis, Inc.
Perlstein Lab
VivoSight OCT
CDx Life
Pulmatrix
Rubicon Genomics, Inc.
Onramp BioInformatics
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$1,900,000
Venture capital - 2018
Global Health Sciences Fund (GHS)
$2,400,000
Seed fund - 2017
Quark Venture
Team Size
2
Employees
I work here
Location
Canada
Headquarters
Explore Canada
$1,900,000
Venture capital
FinSMEs
Sitka Biopharma Raises $1.9M in Funding
Health
$2,400,000
Seed fund
Quark Venture
Quark Venture’s early investment in Sitka Biopharma helps the Vancouver-based company advance to clinical trials
